TRIal to slow the Progression Of Diabetes (TRIPOD): study protocol for a randomized controlled trial using wireless technology and incentives.
Behavior change
Blood glucose monitoring
Diabetes
Financial incentive
Medication adherence
Physical activity
Smartphone apps
Weight monitoring
mHealth
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
28 Nov 2019
28 Nov 2019
Historique:
received:
04
08
2019
accepted:
23
09
2019
entrez:
30
11
2019
pubmed:
30
11
2019
medline:
9
6
2020
Statut:
epublish
Résumé
The outcomes for those with type 2 diabetes mellitus (T2DM) in Singapore are poor. In this TRIal to slow the Progression Of Diabetes (TRIPOD), we will evaluate the effectiveness and cost-effectiveness of a comprehensive diabetes management package (DMP), with or without a financial incentives program, M-POWER Rewards, in efforts to improve HbA TRIPOD is a randomized, open-label, controlled, multi-center, superiority trial with three parallel arms: (1) usual care only, (2) usual care with DMP, and (3) usual care with DMP plus M-POWER Rewards. A total of 339 adults with sub-optimally controlled T2DM (self-reported HbA The TRIPOD study will present insights about the long-term cost-effectiveness and financial viability of the interventions and the potential for integrating within usual care. ClinicalTrials.gov, NCT03800680. Registered on 11 January 2019.
Sections du résumé
BACKGROUND
BACKGROUND
The outcomes for those with type 2 diabetes mellitus (T2DM) in Singapore are poor. In this TRIal to slow the Progression Of Diabetes (TRIPOD), we will evaluate the effectiveness and cost-effectiveness of a comprehensive diabetes management package (DMP), with or without a financial incentives program, M-POWER Rewards, in efforts to improve HbA
METHODS/DESIGN
METHODS
TRIPOD is a randomized, open-label, controlled, multi-center, superiority trial with three parallel arms: (1) usual care only, (2) usual care with DMP, and (3) usual care with DMP plus M-POWER Rewards. A total of 339 adults with sub-optimally controlled T2DM (self-reported HbA
DISCUSSION
CONCLUSIONS
The TRIPOD study will present insights about the long-term cost-effectiveness and financial viability of the interventions and the potential for integrating within usual care.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov, NCT03800680. Registered on 11 January 2019.
Identifiants
pubmed: 31779678
doi: 10.1186/s13063-019-3749-x
pii: 10.1186/s13063-019-3749-x
pmc: PMC6883710
doi:
Substances chimiques
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
Banques de données
ClinicalTrials.gov
['NCT03800680']
Types de publication
Clinical Trial Protocol
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
650Subventions
Organisme : National Medical Research Council
ID : NMRC/HSRG/0079/2017
Références
Psychol Health. 2015;30(11):1361-85
pubmed: 26181764
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Ann Intern Med. 2012 Mar 20;156(6):416-24
pubmed: 22431674
Patient Educ Couns. 2016 Jun;99(6):926-43
pubmed: 26658704
Trials. 2016 Jul 15;17(1):316
pubmed: 27422389
Diabetes Obes Metab. 2017 Sep;19(9):1295-1305
pubmed: 28417575
Health Qual Life Outcomes. 2013 Aug 13;11:138
pubmed: 23937988
Can Fam Physician. 1999 Apr;45:992, 995, 1004-5
pubmed: 10216799
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
J Womens Health (Larchmt). 2006 May;15(4):379-89
pubmed: 16724886
PLoS One. 2015 Feb 24;10(2):e0118296
pubmed: 25710465
Diabetes Care. 2012 Dec;35(12):2681-9
pubmed: 23173137
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
Lancet Diabetes Endocrinol. 2016 Dec;4(12):983-995
pubmed: 27717766
N Engl J Med. 1997 Jan 23;336(4):309-15
pubmed: 8995096
Diabetes Care. 2011 Jul;34(7):1481-6
pubmed: 21593294
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
JMIR Mhealth Uhealth. 2019 May 24;7(5):e12965
pubmed: 31127720
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Front Psychol. 2018 Nov 06;9:2180
pubmed: 30459694
Ann Intern Med. 2015 Dec 1;163(11):848-60
pubmed: 26414227
J Gen Intern Med. 2014 May;29(5):770-7
pubmed: 24522623
BMC Public Health. 2016 Feb 16;16:153
pubmed: 26880337
Lancet. 2012 Jun 16;379(9833):2252-61
pubmed: 22683130
Am J Health Promot. 2018 Sep;32(7):1613-1626
pubmed: 29658286
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Appetite. 2013 Jun;65:83-9
pubmed: 23402712
Open Med. 2010;4(2):e102-13
pubmed: 21686299
JAMA. 2012 Jun 27;307(24):2617-26
pubmed: 22735431
Health Psychol. 2014 Sep;33(9):1057-64
pubmed: 24295025
Trials. 2017 Nov 17;18(1):551
pubmed: 29149912
Br J Health Psychol. 2014 Feb;19(1):52-64
pubmed: 23406475
J Womens Health Gend Based Med. 2002 Jul-Aug;11(6):519-26
pubmed: 12243129
BMJ Open Diabetes Res Care. 2014 Jun 11;2(1):e000012
pubmed: 25452860